JP2023522588A5 - - Google Patents
Info
- Publication number
- JP2023522588A5 JP2023522588A5 JP2022561113A JP2022561113A JP2023522588A5 JP 2023522588 A5 JP2023522588 A5 JP 2023522588A5 JP 2022561113 A JP2022561113 A JP 2022561113A JP 2022561113 A JP2022561113 A JP 2022561113A JP 2023522588 A5 JP2023522588 A5 JP 2023522588A5
- Authority
- JP
- Japan
- Prior art keywords
- patient
- antigens
- antigen
- polynucleotide
- portions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA202070221 | 2020-04-09 | ||
| DKPA202070221 | 2020-04-09 | ||
| DKPA202070338 | 2020-05-26 | ||
| DKPA202070338 | 2020-05-26 | ||
| PCT/EP2021/059353 WO2021205027A1 (en) | 2020-04-09 | 2021-04-09 | Individualized therapeutic anticancer vaccine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023522588A JP2023522588A (ja) | 2023-05-31 |
| JP2023522588A5 true JP2023522588A5 (https=) | 2024-04-18 |
Family
ID=75539309
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022561113A Pending JP2023522588A (ja) | 2020-04-09 | 2021-04-09 | 個別化された治療用抗がんワクチン |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230293650A1 (https=) |
| EP (1) | EP4132565A1 (https=) |
| JP (1) | JP2023522588A (https=) |
| KR (1) | KR20230004585A (https=) |
| CN (1) | CN115397462A (https=) |
| AU (1) | AU2021252155A1 (https=) |
| BR (1) | BR112022020277A2 (https=) |
| CA (1) | CA3172191A1 (https=) |
| IL (1) | IL297049A (https=) |
| MX (1) | MX2022012671A (https=) |
| WO (1) | WO2021205027A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20230164118A (ko) | 2021-03-26 | 2023-12-01 | 니코데 테라퓨틱스 에이에스에이 | 암 치료를 위한 치료 조합 |
| WO2022233851A1 (en) | 2021-05-03 | 2022-11-10 | Nykode Therapeutics ASA | Immunogenic constructs and vaccines for use in the prophylactic and therapeutic treatment of infectious diseases |
| BR112023023260A2 (pt) | 2021-05-10 | 2024-01-30 | Nykode Therapeutics ASA | Vetor, métodos para produzir um vetor e para tratar um sujeito tendo uma doença ou uma doença infecciosa, célula hospedeira, e, composição farmacêutica |
| WO2022238381A2 (en) | 2021-05-10 | 2022-11-17 | Nykode Therapeutics ASA | Immunotherapy constructs for treatment of disease |
| WO2022238363A1 (en) | 2021-05-10 | 2022-11-17 | Nykode Therapeutics ASA | Immunogenic constructs and vaccines for use in the prophylactic and therapeutic treatment of infectious diseases |
| WO2024092025A1 (en) | 2022-10-25 | 2024-05-02 | Nykode Therapeutics ASA | Constructs and their use |
| WO2024100196A1 (en) | 2022-11-09 | 2024-05-16 | Nykode Therapeutics ASA | Co-expression of constructs and polypeptides |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112014015016B1 (pt) | 2011-12-21 | 2023-10-03 | Nykode Therapeutics ASA | Proteína homodimérica de duas cadeias de aminoácidos idênticas,cadeia de aminoácido, molécula de ácido nucléico, composição farmacêutica,célula hospedeira, método de preparação de uma proteína homodimérica, método de preparação de uma vacina e vacina |
| EP3417874B1 (en) * | 2012-11-28 | 2024-09-11 | BioNTech SE | Individualized vaccines for cancer |
| IL260030B2 (en) * | 2016-01-08 | 2025-12-01 | Nykode Therapeutics ASA | Therapeutic anticancer neoepitope vaccine |
-
2021
- 2021-04-09 WO PCT/EP2021/059353 patent/WO2021205027A1/en not_active Ceased
- 2021-04-09 MX MX2022012671A patent/MX2022012671A/es unknown
- 2021-04-09 IL IL297049A patent/IL297049A/en unknown
- 2021-04-09 US US17/995,780 patent/US20230293650A1/en active Pending
- 2021-04-09 AU AU2021252155A patent/AU2021252155A1/en active Pending
- 2021-04-09 JP JP2022561113A patent/JP2023522588A/ja active Pending
- 2021-04-09 BR BR112022020277A patent/BR112022020277A2/pt unknown
- 2021-04-09 CN CN202180027619.XA patent/CN115397462A/zh active Pending
- 2021-04-09 KR KR1020227039313A patent/KR20230004585A/ko active Pending
- 2021-04-09 CA CA3172191A patent/CA3172191A1/en active Pending
- 2021-04-09 EP EP21719082.6A patent/EP4132565A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023522588A5 (https=) | ||
| JP7535489B2 (ja) | 治療用抗癌ネオエピトープワクチン | |
| JP7072467B2 (ja) | 乳癌再発の予防のためのワクチン | |
| Dakappagari et al. | A chimeric multi-human epidermal growth factor receptor-2 B cell epitope peptide vaccine mediates superior antitumor responses | |
| JP4422903B2 (ja) | 癌抑制遺伝子ｗｔ１の産物に基づく癌抗原 | |
| ES2849187T3 (es) | Método para activar células T auxiliares | |
| WO2005095598A1 (ja) | Ｗｔ１由来の癌抗原ペプチド | |
| PT1659178E (pt) | Processo para a purificação ou produção de uma proteína mage | |
| WO2004026897A1 (ja) | Ｗｔ１置換型ペプチド | |
| CN115397462A (zh) | 个体化治疗性抗癌疫苗 | |
| TW200902049A (en) | Fusion protein | |
| CA2730686A1 (en) | Anti-amyloid immunogenic compositions, methods and uses | |
| WO2015002134A1 (ja) | 細胞性免疫誘導ワクチン | |
| JP2022517236A (ja) | 自己組織化ペプチドナノ粒子およびその使用 | |
| JP2023521722A (ja) | Ａｐｃ標的化単位を用いたネオエピトープ免疫療法 | |
| JP2006523185A (ja) | 改良された熱ショックタンパク質に基づくワクチンおよび免疫療法 | |
| RS63080B1 (sr) | Kompozicija vakcine i njene upotrebe | |
| CN117384298A (zh) | 一种快速规模化生产病毒样颗粒疫苗或药物的方法 | |
| JP2007537143A (ja) | アンジオモチンまたはアンジオモチンをコードするポリヌクレオチドを含むワクチン組成物、および、ワクチン組成物の血管新生に関連した病気の治療のための使用 | |
| JP7385684B2 (ja) | ワクチンの組み合わせ及びその使用方法 | |
| CN119798408A (zh) | 一种识别hpv多抗原表位的tcr及其编码序列 | |
| RU2782422C2 (ru) | Терапевтическая противораковая неоэпитопная вакцина | |
| WO2024066616A1 (zh) | 一种高亲和力pd1蛋白偶联物及其应用 | |
| JP2024511139A (ja) | 癌を治療するための治療的組み合わせ | |
| WO2025257329A2 (en) | Fusion polypeptide and liponanoparticle comprising the same |